Kestra Investment Management LLC purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 208 shares of the company’s stock, valued at approximately $28,000.
A number of other institutional investors also recently modified their holdings of the company. Hollencrest Capital Management bought a new stake in shares of Astera Labs during the 3rd quarter worth $26,000. Geneos Wealth Management Inc. acquired a new position in Astera Labs during the 4th quarter worth $36,000. ORG Wealth Partners LLC bought a new stake in Astera Labs during the fourth quarter valued at about $42,000. US Bancorp DE acquired a new stake in shares of Astera Labs in the third quarter valued at about $46,000. Finally, First Horizon Advisors Inc. bought a new position in shares of Astera Labs in the third quarter worth about $49,000. Institutional investors own 60.47% of the company’s stock.
Astera Labs Stock Down 3.1 %
Shares of ALAB opened at $85.72 on Friday. The company has a 50-day moving average price of $116.72 and a two-hundred day moving average price of $85.13. The stock has a market cap of $13.90 billion and a price-to-earnings ratio of -49.55. Astera Labs, Inc. has a 12 month low of $36.22 and a 12 month high of $147.39.
Analyst Ratings Changes
Several analysts recently weighed in on ALAB shares. Roth Mkm increased their target price on Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Northland Capmk raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 28th. Stifel Nicolaus boosted their target price on shares of Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Morgan Stanley reduced their price target on shares of Astera Labs from $142.00 to $114.00 and set an “equal weight” rating for the company in a report on Tuesday, January 28th. Finally, Needham & Company LLC restated a “buy” rating and issued a $140.00 price target on shares of Astera Labs in a research report on Tuesday, February 11th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $115.33.
Get Our Latest Stock Analysis on Astera Labs
Insider Transactions at Astera Labs
In other news, Director Michael E. Hurlston sold 2,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $92.08, for a total value of $230,200.00. Following the transaction, the director now directly owns 91,794 shares of the company’s stock, valued at $8,452,391.52. The trade was a 2.65 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jitendra Mohan sold 350,680 shares of the stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $89.51, for a total value of $31,389,366.80. Following the sale, the chief executive officer now owns 2,353,655 shares in the company, valued at approximately $210,675,659.05. This trade represents a 12.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 883,370 shares of company stock valued at $86,643,058.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories
- Five stocks we like better than Astera Labs
- What Are Dividend Contenders? Investing in Dividend Contenders
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- How to Use the MarketBeat Dividend Calculator
- DuPont’s Electronics Spinoff: The Start of Something Big
- Short Selling: How to Short a Stock
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.